ABBV-461

· AbbVie

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABBV-461, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer [Phase 1]